Sanming City issued the "Notice on Further Regulating the Purchase of Medical Equipment " (hereinafter referred to as the "Notice"), which requires the regulation of the procurement of medical equipment in medical and health institutions, the removal of intermediate links in the procurement of medical equipment, the squeezing of medical equipment, the high price of water, and the prevention of medical care. Waste of equipment resources to prevent the occurrence of corrupt practices in medical equipment procurement. The document specifically proposes 6 points:
1. The procurement of medical equipment of medical and health institutions at all levels shall be purchased according to the actual medical needs of the unit. After the collective research of the unit (signature of the members of the unit), the relevant information of the decision-making process shall be attached and reported to the same level of health. And the financial department approves.
Second, the procurement of medical equipment at all levels of medical and health institutions should adhere to the principle of first domestic and post-import, and preferentially purchase domestically produced similar products. Medical institutions can only directly purchase and purchase medical equipment manufacturing enterprises (or national distributors of imported equipment).
Third, the implementation of "one-vote system" procurement. Medical equipment manufacturers (or national distributors of imported equipment) directly issue VAT invoices to medical and health institutions, and are not allowed to “pass the money†or “money laundering†to third parties.
4. The medical equipment purchased by each medical and health institution must be a common name, a general model, and a general specification. It must not be deliberately "tailor-made" (special specifications, special models) and avoid competition; the reagent port and use specification of the equipment must not be closed. Reagent brand; used after the approval of fully enclosed instruments.
5. The purchase price of medical equipment won by the medical and health institutions at all levels must be disclosed on the website of Health Sanming.com, the Municipal Health Planning Commission and the website of the unit, and accept social supervision.
6. Units and responsible persons who violate the regulations in the procurement process of equipment or seriously exceed the ex-factory price and accept bribes shall be dealt with seriously in accordance with relevant laws and regulations.
Can the flexible mode reduce the price?
The author believes that the introduction of this document is correct, support domestic medical device brands, reduce the transaction price of medical equipment by reducing intermediate links. This regulation will lead to a major reshuffle in the medical equipment sector in Sanming. 99% of the local medical equipment will be out of the market, causing great market turmoil, as less than 1% of medical equipment companies currently use direct sales.
The reason why the agency system will become the mainstream sales model of China's pharmaceutical, medical equipment, industrial products, fast-moving consumer goods, durable consumer goods and other industries is because it makes up for the shortage of resources such as manpower, capital and time of the production enterprises, especially Medical device manufacturers effectively evade business risks. The agency system has existed in various industries in China for several decades, and there is certain rationality.
For the "Notice", local agents and medical device manufacturers will also adopt a flexible means, that is, on the surface, medical equipment manufacturers operate, agents are still involved. After the medical equipment is awarded, the manufacturer distributes part of the profit to the agent. Now some agents have cooperated with the hospital as a manufacturer sales manager to carry out business. If the agents and manufacturers in Sanming area operate like this, can the transaction price of medical equipment be reduced?
Price management should be unsuitable
Why can the monitor be reduced from more than 100,000 yuan to less than 20,000 yuan now? It is because Shenzhen Mindray monitor has long been ranked first in the Chinese monitor market! Why did the heart stent drop from more than 100,000 yuan to less than 20,000 yuan now? It is not dominated by the government, but dominated by the market. 70% of the market for heart stents is occupied by domestic brands such as Lepu, MicroPort, and Jiwei. Therefore, the government should consider how to support domestic medical device companies, because the prices of domestic brands occupying leading positions are very low.
In the past two years, the price cuts have swept the entire high-value consumables bidding, and also affected ordinary medical consumables and testing reagents. The lowest bid is a problem, and the disappearance of cheap drugs is an example. The lowest price won the bid will bring product quality hazards, there will always be medical device manufacturers to meet the low price to reduce product quality, bring more medical accidents (low price makes doctors give up high accuracy, expensive inspection items, take accurate Low-cost, low-cost test items, increase the rate of missed diagnosis, error rate), increase more contradictions between doctors and patients, affect doctors' diagnosis and treatment plan (some medical device companies abandon the standard due to low bidding price), crack down on innovative medical care The enthusiasm of the equipment company.
Over the past 30 years of reform and opening up, China's service industry has developed rapidly. We can eat all kinds of cuisines from all over the world, and there are also a variety of novel entertainment methods to choose from. The wearers and the feet can be synchronized with the world. The medical service field still continues the model of the 1980s. It is mainly based on doctors and hospitals. It is not centered on patient needs, and doctor-patient contradictions are frequently seen in the media.
Whether the diversified medical treatment advocated by the state can solve the problem of difficult medical treatment and expensive medical treatment, let us wait and see!
The efficacy and role of small molecule peptides:
1. The small molecule peptide has a simple structure and small molecular weight, the cell membrane can freely penetrate into the cell, and the cell absorption and utilization efficiency is high;
2. Small molecule peptides participate in the synthesis of enzymes, but also increase the activity of enzymes and promote the smooth progress of biological reactions;
3. Small molecule polypeptides can improve the permeability of gastrointestinal mucosa, capillary walls, alveoli and other intermediate metabolic membranes, so as to better absorb nutrients, filter toxins, and prevent the invasion of pathogens;
4. Small molecule peptides can also synthesize specific proteins and produce special effects in the body. At the same time, small molecule peptides can not only supplement the nutrition of cells, but also improve the function and state of cells.
Small Molecule Peptide,Small Molecule Collagen Peptide,Small Molecule Active Peptide,Molecule Peptide
SHAANXI HAIBO BIOTECHNOLOGY CO., LTD , https://www.rozenbio.com